Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients

MLA

Chara Stavraka, et al. “Clinical Implementation of Pre-Treatment DPYD Genotyping in Capecitabine-Treated Metastatic Breast Cancer Patients.” Breast Cancer Research and Treatment, vol. 175, Feb. 2019, pp. 511–17. EBSCOhost, https://doi.org/10.1007/s10549-019-05144-9.

APA

Chara Stavraka, Janine Mansi, Karen DeSouza, Anthony M. Marinaki, E. Karapanagiotou, Matthaios Kapiris, Athanasios Pouptsis, Leroy Okonta, Dionysis Papadatos-Pastos, & Philip Charlton. (2019). Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients. Breast Cancer Research and Treatment, 175, 511–517. https://doi.org/10.1007/s10549-019-05144-9

Chicago

Chara Stavraka, Janine Mansi, Karen DeSouza, Anthony M. Marinaki, E. Karapanagiotou, Matthaios Kapiris, Athanasios Pouptsis, Leroy Okonta, Dionysis Papadatos-Pastos, and Philip Charlton. 2019. “Clinical Implementation of Pre-Treatment DPYD Genotyping in Capecitabine-Treated Metastatic Breast Cancer Patients.” Breast Cancer Research and Treatment 175 (February): 511–17. doi:10.1007/s10549-019-05144-9.